Home Supervision for Preventing Injuries
Trial Summary
What is the purpose of this trial?
The investigators will pilot test (N=100 caregivers of children ages 3-4 years) the effects of a caregiver supervision intervention on caregivers' supervision and children's injury frequency using a Randomized Controlled Trial (RCT) design. The control group will receive Services as Usual (SAU), and the treatment group will receive SAU+ SHS. The results will be used to support an R01 application to conduct a larger-scale RCT test of the program.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment SHS, Supervision Intervention, Home Supervision Program?
Research shows that the Supervising for Home Safety (SHS) program helps caregivers improve their supervision practices and beliefs about injury prevention, which reduces the risk of injuries in children. The program has been adapted for different communities, including low-income families, and has been shown to increase parents' awareness of injury risks and the importance of active supervision.12345
Is the Home Supervision Program safe for humans?
The Home Supervision Program, also known as SHS, has been tested in various studies and is generally considered safe. It focuses on improving caregiver supervision to prevent injuries, particularly in children, and has been adapted for different cultural contexts without reported safety concerns.12367
How is the Home Supervision Program (SHS) treatment different from other treatments for preventing injuries?
The Home Supervision Program (SHS) is unique because it focuses on improving caregivers' beliefs and practices regarding supervision to prevent injuries, particularly in young children, by using community-based group delivery and tailored activities. Unlike other treatments that may focus on eliminating hazards, SHS emphasizes changing caregiver behavior and increasing awareness of injury risks.12358
Research Team
Amy Damashek
Principal Investigator
Western Michigan University
Eligibility Criteria
This trial is for primary caregivers, regardless of gender, who have a child aged 3-4 years. They must be able to speak and read English and should not have participated in the related focus group study. It excludes families with children diagnosed with pervasive developmental disorders or those who are blind or deaf.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessments include self-report measures of caregiver supervision beliefs and practices, injury beliefs, and children's injury history, along with an observation of in-home supervision.
Treatment
Participants in the treatment group receive the SHS intervention in addition to Head Start home visiting services for 5 weeks.
Post-test Assessment
Post-test assessments include the same measures as baseline, plus questionnaires on satisfaction and cultural acceptability.
Follow-up
A 1-month follow-up to assess sustainability of effects, including supervision and injury measures.
Treatment Details
Interventions
- SHS
SHS is already approved in United States for the following indications:
- Injury prevention in children ages 3-4 years
Find a Clinic Near You
Who Is Running the Clinical Trial?
Western Michigan University
Lead Sponsor
University of Guelph
Collaborator